skip to main content
DOE Patents title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Polyvalent immunogen

Abstract

The present invention relates, generally, to a polyvalent immunogen and, more particularly, to a method of inducing neutralizing antibodies against HIV and to a polyvalent immunogen suitable for use in such a method.

Inventors:
 [1];  [2];  [1];  [3]
  1. Durham, NC
  2. Los Alamos, NM
  3. Chapel Hill, NC
Issue Date:
Research Org.:
Los Alamos National Lab. (LANL), Los Alamos, NM (United States)
Sponsoring Org.:
USDOE
OSTI Identifier:
936107
Patent Number(s):
7172761
Application Number:
10/431,596
Assignee:
Duke University (Durham, NC); The Regents of The University of California (Oakland, CA)
Patent Classifications (CPCs):
C - CHEMISTRY C07 - ORGANIC CHEMISTRY C07K - PEPTIDES
A - HUMAN NECESSITIES A61 - MEDICAL OR VETERINARY SCIENCE A61K - PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
DOE Contract Number:  
W-7405-ENG-36
Resource Type:
Patent
Country of Publication:
United States
Language:
English
Subject:
60 APPLIED LIFE SCIENCES

Citation Formats

Haynes, Barton F, Korber, Bette T, De Lorimier, Robert M, and Liao, Hua-Xin. Polyvalent immunogen. United States: N. p., 2007. Web.
Haynes, Barton F, Korber, Bette T, De Lorimier, Robert M, & Liao, Hua-Xin. Polyvalent immunogen. United States.
Haynes, Barton F, Korber, Bette T, De Lorimier, Robert M, and Liao, Hua-Xin. Tue . "Polyvalent immunogen". United States. https://www.osti.gov/servlets/purl/936107.
@article{osti_936107,
title = {Polyvalent immunogen},
author = {Haynes, Barton F and Korber, Bette T and De Lorimier, Robert M and Liao, Hua-Xin},
abstractNote = {The present invention relates, generally, to a polyvalent immunogen and, more particularly, to a method of inducing neutralizing antibodies against HIV and to a polyvalent immunogen suitable for use in such a method.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {2007},
month = {2}
}

Patent:

Save / Share:

Works referenced in this record:

Safety and immunogenicity of an HLA-based HIV envelope polyvalent synthetic peptide immunogen
journal, January 1998


HIV Vaccine Development at Duke University Medical Center
journal, January 2000


HIV Type 1 V3 Region Primer-Induced Antibody Suppression Is Overcome by Administration of C4-V3 Peptides as a Polyvalent Immunogen
journal, February 1995


Phage display of peptide epitopes from HIV-1 elicits strong cytolytic responses
journal, August 2000